Immunogenicity of recombinant vaccinia viruses expressing hepatitis B virus surface antigen in miceGRIGORIEVA, I. M; GRIGORIEV, V. G; ZAKHAROVA, L. G et al.Immunology letters. 1993, Vol 36, Num 3, pp 267-271, issn 0165-2478Article

Heterogeneity of hepatitis B virus surface antigen in sera of patients with acute hepatitis B infection in relative content of the antigenic determinants a and preS2GRIGORIEV, V. G; GRIGORIEVA, I. M; ALTSTEIN, A. D et al.Immunology letters. 1993, Vol 36, Num 3, pp 289-294, issn 0165-2478Article

Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza virusesALTSTEIN, A. D; GITELMAN, A. K; SHNEIDER, A. M et al.Archives of virology. 2006, Vol 151, Num 5, pp 921-931, issn 0304-8608, 11 p.Article

Genetic instability of vaccinia virus containing artificially duplicated genome regionsKRIAJEVSKA, M. V; ZAKHAROVA, L. G; ALTSTEIN, A. D et al.Virus research. 1994, Vol 31, Num 1, pp 123-137, issn 0168-1702Article

Viable double vaccinia virus recombinants with the non-inducible phage T7 expression systemKRIAJEVSKA, M. V; ZAKHAROVA, L. G; ALTSTEIN, A. D et al.Journal of general virology. 1993, Vol 74, pp 47-53, issn 0022-1317, 1Article

Two vaccinia virus recombinants expressing HBsAg with different concentration of A- and pre-S2 antigenic determinantsCHELYAPOV, N. V; RAKHILINA, L. E; HAMSIKOVA, E et al.Acta virologica (English ed.). 1991, Vol 35, Num 5, pp 413-422, issn 0001-723XArticle